HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Feng Sun Selected Research

Cadherins (E-Cadherin)

5/2021[In vivo and in vitro Experiment of E74-Like Factor 5 Overexpression Inhibiting the Biological Behavior of Colon Cancer Cells].
1/2021Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Feng Sun Research Topics

Disease

96Neoplasms (Cancer)
12/2024 - 02/2002
75Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2002
52Rectal Neoplasms (Rectal Cancer)
12/2024 - 09/2004
35Neoplasm Metastasis (Metastasis)
09/2023 - 01/2002
31Colonic Neoplasms (Colon Cancer)
02/2024 - 06/2008
16Lymphatic Metastasis
08/2013 - 03/2005
11Adenocarcinoma
01/2023 - 07/2003
5Necrosis
11/2020 - 03/2005
5Stomach Neoplasms (Stomach Cancer)
07/2020 - 12/2004
5Carcinogenesis
10/2018 - 11/2005
5Pancreatitis
01/2017 - 04/2010
4Adenoma (Adenomas)
08/2015 - 01/2008
4Meningioma (Meningiomas)
12/2011 - 01/2006
3Cysts
02/2021 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2021 - 11/2005
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2020 - 03/2005
3Lung Injury
11/2020 - 01/2016
3Microsatellite Instability
08/2015 - 02/2002
2Arteriovenous Fistula
01/2023 - 01/2023
2Chronic Hepatitis B
05/2021 - 04/2012
2Mitochondrial Diseases (Mitochondrial Disease)
08/2020 - 08/2010
2Inflammation (Inflammations)
03/2016 - 01/2013
2Infections
11/2015 - 04/2012
2Esophageal Squamous Cell Carcinoma
01/2013 - 01/2008
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2012 - 05/2012
2Iron Overload
08/2010 - 02/2009
2Melanoma (Melanoma, Malignant)
07/2008 - 07/2007
2Carcinoma (Carcinomatosis)
01/2007 - 08/2004
1Pathologic Processes
03/2024
1Cardiovascular Diseases (Cardiovascular Disease)
09/2023

Drug/Important Bio-Agent (IBA)

66Proteins (Proteins, Gene)FDA Link
11/2023 - 02/2002
26Biomarkers (Surrogate Marker)IBA
11/2023 - 07/2007
15Messenger RNA (mRNA)IBA
11/2020 - 07/2003
14MicroRNAs (MicroRNA)IBA
12/2023 - 01/2009
12Cysteine (L-Cysteine)FDA Link
04/2014 - 11/2004
11Histidine (L-Histidine)FDA Link
11/2013 - 11/2004
9Fluorouracil (Carac)FDA LinkGeneric
02/2024 - 08/2004
7DNA (Deoxyribonucleic Acid)IBA
02/2019 - 02/2002
7Calcibiotic Root Canal SealerIBA
03/2014 - 01/2008
6Indicators and Reagents (Reagents)IBA
01/2022 - 11/2004
6SurvivinIBA
01/2020 - 09/2004
6IntegrinsIBA
11/2016 - 11/2004
6Biological FactorsIBA
12/2013 - 01/2006
5RNA (Ribonucleic Acid)IBA
03/2024 - 02/2012
5EnzymesIBA
11/2020 - 08/2004
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2010 - 11/2004
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2024 - 11/2015
4Small Interfering RNA (siRNA)IBA
05/2021 - 04/2013
4CeruletideIBA
01/2017 - 04/2010
4ParaffinIBA
08/2014 - 01/2011
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2014 - 02/2008
4N 30IBA
01/2012 - 11/2005
3CateninsIBA
12/2024 - 01/2021
3Capecitabine (Xeloda)FDA Link
11/2020 - 03/2014
3Cisplatin (Platino)FDA LinkGeneric
07/2020 - 08/2012
3Carrier Proteins (Binding Protein)IBA
01/2020 - 02/2012
3AmylasesFDA Link
01/2017 - 01/2016
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2011 - 06/2006
3LipidsIBA
01/2010 - 02/2008
3Tumor Protein p73IBA
07/2006 - 01/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2006 - 04/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2023 - 01/2019
2Therapeutic UsesIBA
07/2023 - 01/2016
2Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2022 - 03/2005
2Chromogranin AIBA
05/2022 - 06/2019
2Cadherins (E-Cadherin)IBA
05/2021 - 01/2021
2Estrogen ReceptorsIBA
02/2021 - 01/2018
2Tumor Biomarkers (Tumor Markers)IBA
06/2019 - 08/2012
2ZearalenoneIBA
10/2018 - 01/2018
2Bevacizumab (Avastin)FDA Link
01/2018 - 11/2015
2Sirolimus (Rapamycin)FDA Link
01/2018 - 10/2013
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
09/2017 - 03/2011
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 03/2016
2Leucovorin (Folinic Acid)FDA Link
11/2015 - 12/2004
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2015 - 07/2011
2Matrix Metalloproteinase 7 (Matrilysin)IBA
02/2014 - 01/2007
2hydrogen sulfite (bisulfite)IBA
08/2012 - 05/2012
2Caspase 10IBA
12/2011 - 01/2008
2Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2011 - 01/2003
2IronIBA
08/2010 - 02/2009
2Oxidants (Oxidizing Agents)IBA
08/2010 - 02/2009
2Mitochondrial DNA (mtDNA)IBA
08/2010 - 02/2009
2Estrogens (Estrogen)FDA Link
01/2010 - 11/2005
2Codon (Codons)IBA
07/2008 - 01/2003
2Matrix Metalloproteinases (MMPs)IBA
10/2006 - 01/2004
1Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA
03/2024
1Lys(8)- oxytocin (OXL)IBA
02/2024
1Conditioned Culture MediaIBA
10/2023
1CholesterolIBA
09/2023

Therapy/Procedure

43Radiotherapy
12/2024 - 09/2004
21Therapeutics
12/2023 - 10/2006
15Drug Therapy (Chemotherapy)
12/2024 - 08/2004
3Immunotherapy
12/2024 - 01/2023
3Adjuvant Chemotherapy
01/2023 - 08/2004
2Precision Medicine
12/2023 - 01/2023
2Renal Dialysis (Hemodialysis)
01/2023 - 01/2023
2Chemoradiotherapy
07/2020 - 11/2019
2Neoadjuvant Therapy
11/2015 - 12/2014
1Subcutaneous Injections
12/2023
1Secondary Prevention
09/2023